SEP 16, 2021 9:10 AM PDT

Advanced Data Acquisition Approaches to Multiplexed Single Cell Analysis

C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Single cell proteomics was revolutionized by the introduction of SCoPE-MS, a method that utilizes a carrier proteome added at 20x to 500x single cell channels to enable peptide detection, selection, and quantification. Recently, it has been demonstrated that adding excess carrier proteome may increase measurement variability as well as decrease measurement accuracy and dynamic range. This can be overcome by decreasing the amount of carrier proteome or increasing the number of ions sampled - but quantitative analysis is impacted at some level by the presence of carrier proteome reporter ions. Here, we introduce two advanced data acquisition approaches that utilize a carrier proteome labeled with an offset mass chemical tag (i.e., TMT-SH) that separates the carrier proteome peptide cluster from the multiplexed single cell proteomes and enables quantification of single cells in the absence of carrier proteome reporter ions. The first approach SureQuant-TMT enables the monitoring of up to 10,000 peptides derived from a TMT-SH labeled proteome, real-time peptide identification by peak matching, and subsequent selection of endogenous, multiplexed single cell samples only when a carrier proteome peptide is identified. This technique improves proteomics depth in both MS2 and MS3 analyses for peptides on the user’s inclusion list. The second approach introduces a novel API programming platform, called inSeqAPI, that enables facile construction of real-time data analysis methods. We demonstrate its utility by constructing a method that performs a real-time search on a TMT-SH labeled carrier proteome and triggers quantitative MS2 or MS3 analysis on endogenous TMT labeled single cell proteomes only when a carrier proteome peptide is identified. This unbiased approach enables deep proteomic analysis and sensitive quantification of single cell proteomes by quantifying peptides only after they are identified and removing the carrier proteome from isolation during quantitative scans.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAR 30, 2021 8:00 AM PDT
MAR 30, 2021 8:00 AM PDT
DATE: March 30, 2021 TIME: 08:00am PST In this talk, we will discuss the value of moving towards modular and automated, closed-system technologies designed to enable scalable and cost-effect...
APR 21, 2021 10:00 AM PDT
C.E. CREDITS
APR 21, 2021 10:00 AM PDT
Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
APR 07, 2021 9:00 AM PDT
C.E. CREDITS
APR 07, 2021 9:00 AM PDT
One challenge pharmaceutical companies face, is moving promising biotherapeutic products into the clinic as fast as safely possible. Devoting the correct amount of time and resources to earl...
Loading Comments...
Show Resources